Bruce Donald's company featured at Duke Venture Day

Gavilan Biodesign Company Logo
GCB News

Bruce Donald's company featured at Duke Venture Day

Bruce Donald’s company, Gavilán Biodesign, was featured as one of eight Duke start-up investments at the first Duke Venture Day earlier this month. This event showcased therapeutic innovations currently coming out of Duke. Gavilan Biodesign was recently selected as one of 11 early-stage biotech companies at the Silicon Valley biotech accelerator, IndieBio. Their technology combines state of the art physics-based modeling with a unique high accuracy AI platform to computationally screen trillions of molecules in order to find therapeutics that can overcome resistance. 

Story adopted from an article originally posted on the Office of Licensing and Ventures on May 9, 2019.

Related News

A cross-section of zebrafish gut showing the junctions between epithelial cells in green and a protein expressed on absorptive cells in pink.

Zebrafish Researchers Discover a Self-Defense Mechanism of the Gut

Banned painkiller had a unique effect on the model fish, so they shifted focus to figure out why
Stack of Books

Research Roundup: July 2019

Here are summaries of a selection of the papers published by GCB faculty in July 2019:

flow chart that shows how diet impacts healthy humans and mice vs tumor bearing mice

Science of Metabolism Provides Insight on Using a Nutrient to Slow Cancer

Early studies suggest restricting an amino acid works similarly to chemotherapy, radiation
By Sarah Avery